Steven Pfanstiel Marinus Pharmaceuticals, Inc. (MRNS) insider trading activity

Steven Pfanstiel is CFO AND COO of MARINUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 79,773 shares of MRNS, which is worth approximately $19,145. The most recent transaction as insider was on Aug 05, 2024, when has been sold 4,657 shares (Common Stock) at a price of $1.13 per share, resulting in proceeds of $5,262. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.8K

0% 3M change

61.73% 12M change

Total Value Held $19,145

Steven Pfanstiel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 05 2024	SELL Open market or private sale	$5,262 $1.13 p/Share	4,657 Reduced 5.52%	79,773 Common Stock
Jun 18 2024	BUY Grant, award, or other acquisition	-	12,733 Added 13.1%	84,430 Common Stock
Feb 16 2024	SELL Open market or private sale	$30,827 $9.97 p/Share	3,092 Reduced 4.13%	71,697 Common Stock
Jan 18 2024	BUY Grant, award, or other acquisition	-	25,465 Added 25.4%	74,789 Common Stock
Aug 08 2023	SELL Open market or private sale	$125 $8.93 p/Share	14 Reduced 0.03%	49,324 Common Stock
Aug 07 2023	SELL Open market or private sale	$26,616 $9.54 p/Share	2,790 Reduced 5.35%	49,338 Common Stock
Jan 26 2023	BUY Grant, award, or other acquisition	-	28,130 Added 35.05%	52,128 Common Stock
May 24 2022	BUY Grant, award, or other acquisition	-	7,448 Added 23.69%	23,998 Common Stock
Feb 04 2022	BUY Grant, award, or other acquisition	-	16,550 Added 50.0%	16,550 Common Stock

Steven Pfanstiel

CFO AND COO

Radnor, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNS shares.

Notify only if

Value

Insider Trading

Get notified when an Marinus Pharmaceuticals, Inc. insider buys or sells MRNS shares.

Notify only if

Operation

Value

Type

News

Receive news related to MARINUS PHARMACEUTICALS, INC.

Track Activities on MRNS

Account